Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

IMPAX LABS INC

  • FDA Approval
  • March 28, 2025, 08:42 UTC
  • 49
  • 0 comments

FDA approve DOXYCYCLINE

Comment Full text

MSN

  • FDA Approval
  • March 28, 2025, 08:42 UTC
  • 52
  • 0 comments

FDA approve LEVETIRACETAM

Comment Full text

SOLENO THERAPEUTICS INC

  • FDA Approval
  • March 27, 2025, 13:35 UTC
  • 49
  • 0 comments

FDA approve DIAZOXIDE CHOLINE

Comment Full text

CHIESI

  • FDA Approval
  • March 27, 2025, 08:47 UTC
  • 55
  • 0 comments

FDA approve DEFERIPRONE

Comment Full text

AMNEAL PHARMS

  • FDA Approval
  • March 27, 2025, 08:47 UTC
  • 53
  • 0 comments

FDA approve COLCHICINE

Comment Full text

EUGIA PHARMA

  • FDA Approval
  • March 27, 2025, 08:47 UTC
  • 56
  • 0 comments

FDA approve PALONOSETRON HYDROCHLORIDE

Comment Full text

AVEVA

  • FDA Approval
  • March 27, 2025, 08:47 UTC
  • 61
  • 0 comments

FDA approve LIDOCAINE

Comment Full text

PANACEA

  • FDA Approval
  • March 27, 2025, 08:47 UTC
  • 61
  • 0 comments

FDA approve RIZATRIPTAN BENZOATE

Comment Full text

CHIESI

  • FDA Approval
  • March 27, 2025, 08:47 UTC
  • 45
  • 0 comments

FDA approve DEFERIPRONE

Comment Full text

STRIDES PHARMA

  • FDA Approval
  • March 27, 2025, 08:47 UTC
  • 58
  • 0 comments

FDA approve DOXYCYCLINE HYCLATE

Comment Full text
  • Previous
  • 147
  • 148
  • 149
  • 150
  • 151
  • Next

Search

News categories

  • Technical Exchange News(10333)
  • Event(1541)
  • SEC News(176744)
  • FDA Approval(9672)
  • Company Report(721)
  • Business News(118363)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin